You will be redirected to:
Background
Our client is a Medtech company, founded by engineers, who wants to disrupt the way we monitor new-borns' health data.
Challenge
Our client had 3 key challenges to address in order to get their first clinical trial underway: > Cost efficiency > Time saving > Lack of expertise in clinical trials
Approach
Analysed and challenged current strategy put in place by client for conducting its first clinical trial Involvement of regulatory affairs and clinical operations expertise from Keyrus’ team
Key results
01
Successful first clinical trial got approved to next stage by Health authorities
02
New clinical trial that was extended to the US
Benefits
Cost saving, time saving thanks to KLS’ experience in clinical trials
Share this key play
More key plays
Accelerate the compliance process of your product portfolio in line with the new Medical Device Regulation (EU 2017/745)
Accelerate the clinical validation of an anti-Covid treatment, thanks to an agile data management
Lower costs & risks associated with indication extensions, thanks to a robust meta-analysis of clinical data
Adapting service platforms (FSP) functionning to fit the client's new outsourcing strategy
Facilitate the provision of an innovative treatment thanks to a Managed Access Program (MAP)
Efficiently conducting a worldwide phase 2 clinical study with multiple partners
Achieving an end-to-end audit approval from Health Canada
Facilitate data mapping to SDTM by leveraging standardisation and A.I.
Speed up the development of clinical study documents
Medical device approved for Hearing Loss